Pharmaceutical trading & distribution, from India to 40+ countries
SPK Pharma India is a Mumbai-based B2B pharmaceutical trading and distribution company. We supply generic APIs, finished dosage forms, intermediates, and clinical trial materials to licensed distributors, manufacturers, and institutional buyers — governed by the Drugs & Cosmetics Act 1940, State FDA regulations, and DGFT export policy.
Service lines
What we trade
Seven service lines covering the full B2B pharmaceutical trade flow — from generic API sourcing to clinical trial material supply, named-patient programmes, and government procurement.
Generic API Supply
Off-patent active pharmaceutical ingredients manufactured under WHO-GMP. Drug license verification required for every shipment.
Finished Dosage Forms
Tablets, capsules, injectables, and other finished formulations for licensed distributors, hospital procurement, and institutional buyers.
Orphan & Specialty Medicine Sourcing
Rare-disease and specialty medicines sourced globally for named-patient supply, compassionate use, and parallel-import licensing.
Clinical Trial Material Supply
Comparator drugs, rescue medications, co-medications, and investigational product supply with full documentation and global shipping.
Contract Manufacturing Coordination
Coordination with WHO-GMP, US-FDA, and UK-MHRA approved manufacturing facilities for branded generics, vaccines, and neutral-label products.
Parallel Import & Named-Patient Supply
Cross-border sourcing for unmet medical need, parallel import licensing, and named-patient programmes in 40+ destination countries.
Government & Institutional Tenders
Tender participation for government procurement, public health programmes, and institutional buyers. RCMC and IEC documentation maintained.
Compliance framework
Operating under the Indian pharmaceutical trade framework
All transactions are governed by the Drugs and Cosmetics Act 1940 and Rules 1945, State FDA regulations, and DGFT export-import policy. Membership applications in progress with Pharmexcil and FIEO.
Catalogue
Featured products
A selection from our current catalogue of 32 active SKUs. The catalogue spans peptides, reference standards, blends, and specialty compounds. New product lines are added as supplier relationships and regulatory clearances are confirmed.
BPC-157 + TB-500 + GHK-Cu Research Blend
≥99% HPLC (per component, verified before blending) · Lyophilized powder (pre-blended at the defined ratio)
L-Carnitine (Inner Salt)
≥99% HPLC · Lyophilized powder (crystalline)
NAD+ (β-Nicotinamide Adenine Dinucleotide, Disodium Salt)
≥99% HPLC · Lyophilized powder
Tesamorelin
≥99% HPLC · Lyophilized powder
Why SPK Pharma India
Built for the Indian B2B pharma trade
Drug license gating
Every trade order is checked against the buyer's drug license, IEC equivalent, and import authorisation. We do not ship to unverified buyers.
Lot-matched documentation
COA, MSDS, Certificate of Origin (Pharmexcil), commercial invoice, and packing list per shipment. Pharmacopoeial compliance to USP / EP / BP / IH as applicable.
40+ country network
Validated cold-chain shipping and customs documentation across US, EU, UK, Canada, MENA, APAC, and LATAM. RCMC and IEC documentation maintained.
1-day quote SLA
Quote requests answered within one business day. Direct line to the India trade desk. No automated phone trees, no round-robin routing.
Global reach
Shipping to 40+ countries
Validated cold-chain shipping with customs documentation pre-prepared. We work with licensed distributors, hospital procurement, manufacturers, and institutional buyers in:
- United States (US)
- European Union (EU)
- United Kingdom (UK)
- Canada (CA)
- Middle East & North Africa (MENA)
- Asia Pacific (APAC)
- Latin America (LATAM)
Partnership
Open a recurring supply contract with SPK Pharma India
Recurring orders, volume pricing, exclusive territory rights for qualifying partners. Drug license, IEC equivalent, and import authorisation required.